0001209191-14-057715.txt : 20140912
0001209191-14-057715.hdr.sgml : 20140912
20140912160845
ACCESSION NUMBER: 0001209191-14-057715
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140910
FILED AS OF DATE: 20140912
DATE AS OF CHANGE: 20140912
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001411158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251854385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
BUSINESS PHONE: 650-543-7500
MAIL ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
FORMER COMPANY:
FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chanda Sanjay
CENTRAL INDEX KEY: 0001571820
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34973
FILM NUMBER: 141100965
MAIL ADDRESS:
STREET 1: C/O ANACOR PHARMACEUTICALS, INC.
STREET 2: 1020 EAST MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-09-10
0
0001411158
Anacor Pharmaceuticals, Inc.
ANAC
0001571820
Chanda Sanjay
C/O ANACOR PHARMACEUTICALS, INC.
1020 EAST MEADOW CIRCLE
PALO ALTO
CA
94303
0
1
0
0
SVP, Drug Development
Common Stock
2014-09-10
4
M
0
5047
7.25
A
9042
D
Common Stock
2014-09-10
4
S
0
5047
24.25
D
3995
D
Common Stock
2014-09-10
4
M
0
4953
5.00
A
8948
D
Common Stock
2014-09-10
4
S
0
4953
24.25
D
3995
D
Stock Option (right to buy)
7.25
2014-09-10
4
M
0
5047
7.25
D
2018-03-26
Common Stock
5047
9952
D
Stock Option (right to buy)
5.00
2014-09-10
4
M
0
4953
5.00
D
2019-03-26
Common Stock
4953
0
D
Includes 995 shares purchased on July 31, 2014, pursuant to the Issuer's ESPP.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2014.
This option is fully vested and exercisable.
/s/ Lucy O. Day, as Attorney-in-fact
2014-09-12